Skip to main content
Year archive

AVECHO BIOTECHNOLOGY LIMITED — 2008 filings

All 35 regulatory filings released by AVECHO BIOTECHNOLOGY LIMITED (AVE) in 2008, sourced directly from the official regulator.

35 Filings
2008 Period
2008 filings (35)
Filing Released Lang
Positive Phase 1 Clinical Trial for Transdermal Lidocaine 3 pages ?Kb
Regulatory Filings
2008-12-07 English
Transdermal Diclofenac - Phase 1 Human Clinical Trial 2 pages ?Kb
Regulatory Filings
2008-11-11 English
Metabolic Syndrome Phase 2 Clinical Trial Recruitment Status 2 pages ?Kb
Regulatory Filings
2008-11-04 English
POH Presentation - Annual Pain Therapeutics Summit 2008 32 pages ?Kb
Investor Presentation
2008-10-06 English
Change of Director`s Interest Notice Professor J Mills 4 pages ?Kb
Director's Dealing
2008-10-02 English
Initiation of Phase 1 Clinical Trial Transdermal Lidocaine 2 pages ?Kb
Regulatory Filings
2008-09-22 English
AIM Update 2 pages ?Kb
Delisting Announcement
2008-09-21 English
Revised Form 603 - NextGen Pet Ltd 25 pages ?Kb
Regulatory Filings
2008-09-17 English
Becoming a substantial holder 25 pages ?Kb
Regulatory Filings
2008-09-14 English
Half Yearly Report and Accounts 27 pages ?Kb
Regulatory Filings
2008-08-28 English
Phosphagenics July 2008 Newsletter 3 pages ?Kb
Management Reports
2008-07-20 English
Director Appointment Mr Michael ASHTON 2 pages ?Kb
Board/Management Information
2008-07-07 English
Initial Director`s Interest Notice - Mr Michael Ashton 4 pages ?Kb
Director's Dealing
2008-07-07 English
Ceasing to be a substantial holder - Mr H Snook 3 pages ?Kb
Major Shareholding Notification
2008-06-10 English
Final Director`s Interest Notice Appendix 3Z Mr M D Prestion 3 pages ?Kb
Director's Dealing
2008-05-25 English
Chairman`s and CEO Address to Shareholders at AGM 9 pages ?Kb
AGM Information
2008-05-22 English
Results of Annual General Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2008-05-22 English
Change of Director`s Interest Notice - Professor J Mills 4 pages ?Kb
Director's Dealing
2008-05-21 English
Phosphagenics` Executive Appointment 2 pages ?Kb
Board/Management Information
2008-05-19 English
Appendix 3B - Confirmation of Number of Shares Placed 8 pages ?Kb
Share Issue/Capital Change
2008-05-19 English
Change in substantial holding 6 pages ?Kb
Regulatory Filings
2008-05-11 English
POH Capital Raising of A$9.1m-App 3B and S708A Notice 10 pages ?Kb
Capital/Financing Update
2008-05-06 English
Trading Halt 2 pages ?Kb
Capital/Financing Update
2008-05-04 English
Positive Pre-clinical Results Targeted Delivery Lidocane 3 pages ?Kb
Regulatory Filings
2008-04-29 English
Excellence in Biology Investment Conference Presentation 26 pages ?Kb
Investor Presentation
2008-04-20 English
Annual Report and AGM documentation to shareholders 81 pages ?Kb
Regulatory Filings
2008-04-13 English
POH initiates Phase 2 Clinical Trial in Type 1 Diabetes 2 pages ?Kb
Regulatory Filings
2008-03-18 English
GRAS status for Phospha E 2 pages ?Kb
Regulatory Filings
2008-03-17 English
Correction Change of Director`s Interest Notice Mr H Rosen 5 pages ?Kb
Director's Dealing
2008-03-13 English
Change of Director`s Interest Notice - Mr H Rosen 5 pages ?Kb
Director's Dealing
2008-03-12 English
Change of Director`s Interest Notice - Mr H Rosen 5 pages ?Kb
Director's Dealing
2008-03-04 English
Preliminary Final Report and Financial Report 74 pages ?Kb
Annual Report FY 2007
2008-02-26 English
US Clinical Trials - Topical Retinoic Acid 2 pages ?Kb
Regulatory Filings
2008-02-18 English
Progression of Phosphagenics and Nestle`s Phospha E Trial 3 pages ?Kb
Regulatory Filings
2008-02-10 English
Pre-clinical study results - APA-01 and atorvastatin 3 pages ?Kb
Regulatory Filings
2008-01-29 English